Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

Abstract Background Frunevetmab, a felinized antinerve growth factor monoclonal antibody, effectively decreases osteoarthritis (OA) pain in cats. Objective To evaluate the efficacy of frunevetmab given at monthly intervals in a randomized, placebo‐controlled, parallel‐group, double‐blind superiority...

詳細記述

書誌詳細

主要な著者:	Margaret E. Gruen, Jamie A. E. Myers, Jezaniah‐Kira S. Tena, Csilla Becskei, Dawn M. Cleaver, B. Duncan X. Lascelles
フォーマット:	Artigo
言語:	Inglês
出版事項:	Oxford University Press 2021-11-01
シリーズ:	Journal of Veterinary Internal Medicine
主題:	arthritis client specific outcome measures CSOM degenerative joint disease feline feline musculoskeletal pain index
オンライン･アクセス:	https://doi.org/10.1111/jvim.16291
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!